Fabulas

Fabulas (Febuxostat) treats gout by reducing serum uric acid levels. It is classified as a xanthine oxidase inhibitor. Gout occurs due to hyperuricemia, which causes abnormally high blood uric acid levels. Crystals may be formed in the joints from this uric acid, resulting in sudden and extreme pain that is accompanied by swelling and stiffness. Treatment with this medicine aims to manage and prevent gout (but not to treat flare-ups). Its mechanism of action is blocking xanthine oxidase activity (the enzyme that produces uric acid), which causes a decrease in uric acid levels, thereby helping to prevent the occurrence of gout attacks.

Fabulas (Febuxostat) is available as 40mg, 80mg and 120mg strength tablets for oral administration. Physicians generally instruct adult patients treating gout to administer 40mg once per day as a starting dosage. This may be adjusted on the order of the physician, to a maintenance dosage of 80mg per day. However, it is also possible that the dosage will not be adjusted for maintenance treatment. There is a chance that this medicine may cause a gout attack after treatment has commenced, and your physician may recommend taking other medicines to relieve the pain. Eventually, when the uric acid levels are effectively reduced, the occurrence of gout attacks will decline.

If you notice side effects during treatment with Fabulas (Febuxostat) tablets, ensure that you notify your physician. Examples include:

• Vertigo
• Nausea
• Diarrhoea
• Stiff joints
• Soreness in the joints

Other reactions are also possible. You will require immediate medical treatment or a visit to the hospital if you notice numbness, speech problems, perspiration, fainting, difficulty balancing or any other severe adverse events that have not been referenced here.

Fabulas (Febuxostat) is not used to treat acute gout attacks or flare ups, as it is not suitable for this purpose. It is only intended for the prevention and control of symptoms. Another medicine may be recommended by your physician to treat flare ups.

Patients will be required to undergo blood tests to assess the function of their liver before and during the course of treatment.

If you become dizzy as a result of taking this medicine, or if you suffer from drowsiness, do not drive or use machinery, as doing so is extremely hazardous.